Midostaurin price analysis in 2025: How much does a box cost? Interpretation of medical insurance policies

Midostaurinis an oral multi-target kinase inhibitor indicated for the treatment of newly diagnosed adults with FMS-like tyrosine kinase-3 (FLT3) mutationsacute myeloid leukemia (AML), and also applies to advanced systemic mastocytosis (SM), including aggressive systemic mastocytosis (ASM), systemic mastocytosis with hematological neoplasms (SM-AHN) and mast cell leukemia. Midostaurin can effectively prevent the proliferation and spread of cancer cells by inhibiting the activity of multiple kinases, especially FLT3, providing patients with a new treatment option.

In China, the original drug of midostaurin is not yet on the market, nor is it covered by medical insurance. Therefore, the specific domestic price situation is still unclear, but you can refer to the selling price in overseas markets. In the European market, midostaurin is usually sold in the format of 25mg*112 tablets, with a price range between RMB 10,000 and RMB 70,000. This price will fluctuate due to exchange rates and market supply. In addition, India's BDR pharmaceutical factory also produces generic versions of midostaurin, which are relatively affordable at about 3,000 yuan per box, and their drug ingredients are highly consistent with the original drug, providing patients with a viable economic choice.

Since Midostaurin is not yet available in China, patients may face certain difficulties in obtaining the drug, so some patients may choose to purchase it from abroad, especially through purchasing from overseas pharmacies. However, when purchasing overseas medicines, patients need to be cautious and ensure the sources are reliable to avoid the risk of purchasing counterfeit medicines.

In terms of medical insurance policy, since midostaurin has not yet been included in the national medical insurance catalog, this means that patients need to bear all drug costs during treatment. This undoubtedly increases the financial burden on patients, especially in the case of long-term treatment.

Reference materials:https://medlineplus.gov/druginfo/meds/a617033.html